Physician profile
Sandra Wells
NPI 1801347679
$937.95
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $113 · 2023: $342 · 2024: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $186.72 | 2021-2024 | |
| Paratek Pharmaceuticals, INC. | $125.00 | 2023 | Nuzyra |
| Neurelis, INC. | $123.58 | 2023 | Valtoco |
| Neurocrine Biosciences, INC. | $114.86 | 2024 | |
| Inspire Medical Systems, INC. | $112.81 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $73.81 | 2023 | Lokelma |
| Teva Pharmaceuticals USA, INC. | $68.24 | 2024 | Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $35.64 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.33 | 2022-2023 | Ofev |
| Lilly USA, LLC | $27.78 | 2022 | |
| Merck Sharp & Dohme LLC | $13.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.48 | 2022 | |
| Amgen INC. | $11.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.